Abstract
We have recently described a method for radiolabeling monoclonal antibodies, with metallic radionuclides using a new chelating agent N2S3. Using this chelate the monoclonal antibodies Lym-1 and B72.3 were labeled with 186Re and their biological integrity was evaluated in vitro and in vivo. 186Re-labeled antibodies using N2S4 methodology were found to be stable in human serum and retained their immunoreactivity. Intravenous administration of 0.5 mCi 186Re-labeled antibodies resulted in partial or complete regression of tumor tissue in mice.
Original language | English (US) |
---|---|
Pages (from-to) | 205-212 |
Number of pages | 8 |
Journal | International Journal of Radiation Applications and Instrumentation. |
Volume | 19 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1992 |
ASJC Scopus subject areas
- General Medicine